Clinical Trial Update: Study of the Clinical and Biological Efficacity of NAAXIA SINE® in Vernal Keratoconjunctivitis [Phase 4]

View source ↗

Summary

Phase 4 study evaluating the clinical and biological efficacy of NAAXIA SINE in vernal keratoconjunctivitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vernal Keratoconjunctivitis

Drugs mentioned

• NAAXIA SINE

Snippet

Sponsor: Laboratoires Thea | Conditions: Keratoconjunctivitis, Vernal | Phase 4 | Status: COMPLETED